RWM
ABBV icon

Ritholtz Wealth Management’s AbbVie ABBV Stock Holding History

Ritholtz Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-400
Closed -$7K – 536
2021
Q1 		$7K Sell
400
-100
-20% -$10.7K ﹤0.01% 471
2020
Q4 		$7K Buy
+500
New +$48K ﹤0.01% 409

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ritholtz Wealth Management's ABBV Position: Q1 2026 in Review

Ritholtz Wealth Management increased its AbbVie (ABBV) stake by 1% in Q1 2026, buying an estimated $108K and bringing the position to 47,935 shares worth $10.4M. The position accounts for 0.18% of the portfolio, ranked #68.

Ritholtz Wealth Management first reported a position in ABBV in Q4 2017 and has held it in 33 quarters since. The position peaked at $10.8M in Q4 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Ritholtz Wealth Management held 47,935 shares of AbbVie worth $10.4M as of Q1 2026.
  • Ritholtz Wealth Management bought 487 AbbVie shares in Q1 2026, an estimated $108K.
  • AbbVie made up 0.18% of Ritholtz Wealth Management's portfolio in Q1 2026, its #68 holding.
  • Ritholtz Wealth Management first reported a position in AbbVie in Q4 2017 and has held it in 33 quarters since.
  • Ritholtz Wealth Management's AbbVie position peaked at $10.8M in Q4 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Ritholtz Wealth Management's 13F filing for Q1 2026, filed 20 Apr 2026.